These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24697902)

  • 1. Poor glycemic control associates with high intravitreal angiopoietin-2 levels in patients with diabetic retinopathy.
    Tuuminen R; Haukka J; Loukovaara S
    Acta Ophthalmol; 2015 Sep; 93(6):e515-6. PubMed ID: 24697902
    [No Abstract]   [Full Text] [Related]  

  • 2. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment.
    Tuuminen R; Sahanne S; Loukovaara S
    Acta Ophthalmol; 2014 Nov; 92(7):675-81. PubMed ID: 24506800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor-A (VEGF-A) in vitreous fluid of patients with proliferative diabetic retinopathy.
    Kant S; Seth G; Anthony K
    Ann Ophthalmol (Skokie); 2009; 41(3-4):170-3. PubMed ID: 20214050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.
    Sassa Y; Yoshida S; Ishikawa K; Asato R; Ishibashi T; Kono T
    Eye (Lond); 2016 May; 30(5):746-53. PubMed ID: 26915745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy.
    Loukovaara S; Robciuc A; Holopainen JM; Lehti K; Pessi T; Liinamaa J; Kukkonen KT; Jauhiainen M; Koli K; Keski-Oja J; Immonen I
    Acta Ophthalmol; 2013 Sep; 91(6):531-9. PubMed ID: 23106921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated protein carbonyl and HIF-1α levels in eyes with proliferative diabetic retinopathy.
    Loukovaara S; Koivunen P; Inglés M; Escobar J; Vento M; Andersson S
    Acta Ophthalmol; 2014 Jun; 92(4):323-7. PubMed ID: 23718695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy.
    Qian J; Lu Q; Tao Y; Jiang YR
    Retina; 2011 Jan; 31(1):161-8. PubMed ID: 20890241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of preoperative vitreous IL-8 and VEGF levels with visual acuity after vitrectomy in proliferative diabetic retinopathy.
    Petrovič MG; Korošec P; Košnik M; Hawlina M
    Acta Ophthalmol; 2010 Dec; 88(8):e311-6. PubMed ID: 21073666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of alphaB-crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor.
    Chen W; Lu Q; Lu L; Guan H
    Clin Exp Ophthalmol; 2017 May; 45(4):379-384. PubMed ID: 27928876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Vidal MT; García-Arumí J; Carrasco E; García-Ramírez M; Segura RM; Hernández C
    Diabetes Res Clin Pract; 2006 Jan; 71(1):36-44. PubMed ID: 16029908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema.
    Funatsu H; Yamashita H; Nakamura S; Mimura T; Eguchi S; Noma H; Hori S
    Ophthalmology; 2006 Feb; 113(2):294-301. PubMed ID: 16406543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced concentrations of angiogenesis-related factors in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
    Yoshida S; Ishikawa K; Matsumoto T; Yoshida A; Ishibashi T; Kono T
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):799-804. PubMed ID: 20135140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema.
    Praidou A; Papakonstantinou E; Androudi S; Georgiadis N; Karakiulakis G; Dimitrakos S
    Acta Ophthalmol; 2011 May; 89(3):248-54. PubMed ID: 19799585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased intravitreous interleukin-18 correlated to vascular endothelial growth factor in patients with active proliferative diabetic retinopathy.
    Song Z; Sun M; Zhou F; Huang F; Qu J; Chen D
    Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1229-34. PubMed ID: 24531563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.
    Li B; Li MD; Ye JJ; Chen Z; Guo ZJ; Di Y
    Chin Med J (Engl); 2020 Mar; 133(6):664-669. PubMed ID: 32068603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous levels of angiopoietin-1 and angiopoietin-2 in eyes with retinopathy of prematurity.
    Sato T; Shima C; Kusaka S
    Am J Ophthalmol; 2011 Feb; 151(2):353-7.e1. PubMed ID: 21168819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
    Yoshida S; Nakama T; Ishikawa K; Arima M; Tachibana T; Nakao S; Sassa Y; Yasuda M; Enaida H; Oshima Y; Kono T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6997-7003. PubMed ID: 22977138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreous VEGF-A in eyes with massive vitreous hemorrhage.
    Shirasawa M; Arimura N; Otsuka H; Sonoda S; Hashiguchi T; Sakamoto T
    Graefes Arch Clin Exp Ophthalmol; 2011 Dec; 249(12):1805-10. PubMed ID: 21853228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased intravitreal angiopoietin-2 levels in patients with retinal vein occlusion.
    Tuuminen R; Loukovaara S
    Acta Ophthalmol; 2014 Mar; 92(2):e164-5. PubMed ID: 23786639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.